Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS-Guided Loco-regional Chemotherapy Injection for Locally Advanced Pancreatic Cancer
NCT07429643Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Apr 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gemcitabine in pancreatic cancer (PC), sponsored by Assiut University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
gemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07429643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07429643.